Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7WOX

PPARgamma antagonist (MMT-160)- PPARgamma LBD complex

Summary for 7WOX
Entry DOI10.2210/pdb7wox/pdb
DescriptorPeroxisome proliferator-activated receptor gamma, N-[[5-(3-phenylprop-2-ynoylamino)-2-propoxy-phenyl]methyl]-4-pyrimidin-2-yl-benzamide (3 entities in total)
Functional Keywordsppargamma, mtt160, covalent modifier, nuclear hormone receptor, antagonist, transcription
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight63389.59
Authors
Yoshizawa, M.,Aoyama, T.,Itoh, T.,Miyachi, H. (deposition date: 2022-01-22, release date: 2022-04-13, Last modification date: 2024-10-30)
Primary citationYoshizawa, M.,Aoyama, T.,Itoh, T.,Miyachi, H.
Arylalkynyl amide-type peroxisome proliferator-activated receptor gamma (PPAR gamma )-selective antagonists covalently bind to the PPAR gamma ligand binding domain with a unique binding mode.
Bioorg.Med.Chem.Lett., 64:128676-128676, 2022
Cited by
PubMed Abstract: Peroxisome proliferator-activated receptor γ (PPARγ) antagonists are drug candidates for the treatment of type 2 diabetes, obesity, and osteoporosis. Previously, we have designed and synthesized a series of substituted phenylalkynyl amide-type PPARγ antagonists. The representative compound, MMT-160, exhibited nanomolar-order PPARγ antagonistic activity. To understand the antagonistic mode of action of MMT-160, mass spectrometric and X-ray crystallographic analysis of MMT-160 in the presence of the PPARγ ligand binding domain (LBD) were performed. The mass spectrometry results clearly indicated that alkynyl amide-type PPARγ antagonists were covalently bound to the PPARγ LBD. The X-ray crystallographic analysis indicated that MMT-160 acted as a Michael acceptor and covalently bound to the PPARγ LBD via Cys285. In addition, MMT-160 bound to the PPARγ LBD with a binding mode that was different from the binding modes observed for PPARγ agonists and partial agonists.
PubMed: 35301139
DOI: 10.1016/j.bmcl.2022.128676
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.2 Å)
Structure validation

227561

PDB entries from 2024-11-20

PDB statisticsPDBj update infoContact PDBjnumon